Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $74.00 and last traded at $73.79, with a volume of 2757 shares changing hands. The stock had previously closed at $72.98.
Lonza Group Price Performance
The company has a quick ratio of 1.77, a current ratio of 2.24 and a debt-to-equity ratio of 0.42. The business’s fifty day moving average is $68.46 and its two-hundred day moving average is $65.64.
About Lonza Group
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
See Also
- Five stocks we like better than Lonza Group
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
